UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.
Search Articles
The American journal of gastroenterology, ISSN 0002-9270, 02/2017, Volume 112, Issue 2, pp. 212 - 238
Gastroenterology & Hepatology | Life Sciences & Biomedicine | Science & Technology | Humans | Salvage Therapy | Anti-Infective Agents - therapeutic use | Clarithromycin - therapeutic use | Bismuth - therapeutic use | Proton Pump Inhibitors - therapeutic use | Antacids - therapeutic use | Anti-Bacterial Agents - therapeutic use | Helicobacter pylori | Metronidazole - therapeutic use | Helicobacter Infections - drug therapy | Treatment Failure | Amoxicillin - therapeutic use | Levofloxacin - therapeutic use | Drug Therapy, Combination | Index Medicus
Journal Article
The Lancet (British edition), ISSN 0140-6736, 09/2018, Volume 392, Issue 10150, pp. 821 - 834
Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Clofazimine - therapeutic use | Recurrence | Tuberculosis, Multidrug-Resistant - mortality | Linezolid - therapeutic use | Humans | Fluoroquinolones - therapeutic use | Tuberculosis, Pulmonary - drug therapy | Kanamycin - therapeutic use | Moxifloxacin | Capreomycin - therapeutic use | Amikacin - therapeutic use | Carbapenems - therapeutic use | Tuberculosis, Pulmonary - mortality | Diarylquinolines - therapeutic use | Treatment Failure | Antitubercular Agents - administration & dosage | Levofloxacin - therapeutic use | Drug Therapy, Combination | Antitubercular Agents - therapeutic use | Tuberculosis, Multidrug-Resistant - drug therapy | Drug resistance in microorganisms | Care and treatment | Tuberculosis | Patient outcomes | Analysis | Drugs | Fluoroquinolones | Linezolid | Levofloxacin | Amikacin | Clinical trials | Systematic review | Drug resistance | Success | Clinical outcomes | Literature reviews | Heterogeneity | Kanamycin | Data analysis | Clofazimine | Adjustment | Mortality | Data processing | Thorax | Regression analysis | Disease control | Patients | Capreomycin | Meta-analysis | Studies | Multidrug resistant organisms | Infectious diseases | Adults | Respiration | Carbapenems | Index Medicus | Abridged Index Medicus | Medicin och hälsovetenskap
Journal Article
Frontiers in cellular and infection microbiology, ISSN 2235-2988, 05/2017, Volume 7, Issue MAY, pp. 168 - 168
Infection | Resistance | Treatment | Helicobacter pylori | Reinfection | Immunology | Life Sciences & Biomedicine | Microbiology | Science & Technology | Prevalence | Humans | Helicobacter pylori - genetics | Helicobacter pylori - drug effects | Bismuth - therapeutic use | Furazolidone - therapeutic use | Anti-Bacterial Agents - therapeutic use | Metronidazole - therapeutic use | Helicobacter Infections - drug therapy | Levofloxacin - therapeutic use | Drug Resistance, Bacterial - drug effects | Drug Resistance, Bacterial - genetics | Pyrroles - therapeutic use | Helicobacter Infections - epidemiology | Tetracycline - therapeutic use | Clarithromycin - therapeutic use | Tetracycline Resistance | Proton Pump Inhibitors - therapeutic use | Drug Therapy, Combination - methods | Anti-Bacterial Agents - classification | Sulfonamides - therapeutic use | Amoxicillin - therapeutic use | Rifabutin - therapeutic use | Probiotics - therapeutic use | Mutation | Anti-Bacterial Agents - administration & dosage | Helicobacter Infections - microbiology | Index Medicus | treatment | infection | reinfection | resistance
Journal Article
4.
Full Text
Best drug treatment for multidrug-resistant and extensively drug-resistant tuberculosis
The Lancet infectious diseases, ISSN 1473-3099, 2010, Volume 10, Issue 9, pp. 621 - 629
Infectious Disease | Life Sciences & Biomedicine | Infectious Diseases | Science & Technology | Biological and medical sciences | Infectious diseases | Medical sciences | Bacterial diseases | Human bacterial diseases | Tuberculosis and atypical mycobacterial infections | Extensively Drug-Resistant Tuberculosis - drug therapy | Levofloxacin | Drug Resistance, Multiple | Humans | Ofloxacin - therapeutic use | Fluoroquinolones - therapeutic use | Kanamycin - therapeutic use | Pyrazinamide - therapeutic use | Capreomycin - therapeutic use | Amikacin - therapeutic use | Antitubercular Agents - classification | Tuberculosis - drug therapy | Antitubercular Agents - standards | Isoniazid - therapeutic use | Ethambutol - therapeutic use | Antitubercular Agents - therapeutic use | Drugs | Drug resistance in microorganisms | Care and treatment | Tuberculosis | Amoxicillin | Antitubercular agents | Index Medicus
Journal Article